Colleen Sweeney

Title(s)Professor, Biochemistry and Molecular Medicine
SchoolSchool of Medicine
AddressResearch III/UCDMC
CA 95817
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer. Cells. 2023 05 20; 12(10). Kado SY, Bein K, Castaneda AR, Pouraryan AA, Garrity N, Ishihara Y, Rossi A, Haarmann-Stemmann T, Sweeney CA, Vogel CFA. PMID: 37408267; PMCID: PMC10216785.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer. Front Pharmacol. 2022; 13:1095289. Sweeney C, Lazennec G, Vogel CFA. PMID: 36588678; PMCID: PMC9797527.
      View in: PubMed   Mentions: 4  
    3. Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer. Br J Cancer. 2022 08; 127(3):436-448. Umeh-Garcia M, O'Geen H, Simion C, Gephart MH, Segal DJ, Sweeney CA. PMID: 35440669; PMCID: PMC9346006.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    4. Aryl Hydrocarbon Receptor Signaling Synergizes with TLR/NF-κB-Signaling for Induction of IL-22 Through Canonical and Non-Canonical AhR Pathways. Front Toxicol. 2021; 3:787360. Ishihara Y, Kado SY, Bein KJ, He Y, Pouraryan AA, Urban A, Haarmann-Stemmann T, Sweeney C, Vogel CFA. PMID: 35295139; PMCID: PMC8915841.
      View in: PubMed   Mentions: 10  
    5. Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development. Front Immunol. 2021; 12:625346. Vogel CFA, Lazennec G, Kado SY, Dahlem C, He Y, Castaneda A, Ishihara Y, Vogeley C, Rossi A, Haarmann-Stemmann T, Jugan J, Mori H, Borowsky AD, La Merrill MA, Sweeney C. PMID: 33763068; PMCID: PMC7982668.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    6. Effect of a patient-led educational session on pre-clerkship students' learning of professional values and on their professional development. Med Educ Online. 2020 Dec; 25(1):1801174. Butani L, Sweeney C, Plant J. PMID: 32730189; PMCID: PMC7482741.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun. 2020 09 14; 11(1):4591. Candas-Green D, Xie B, Huang J, Fan M, Wang A, Menaa C, Zhang Y, Zhang L, Jing D, Azghadi S, Zhou W, Liu L, Jiang N, Li T, Gao T, Sweeney C, Shen R, Lin TY, Pan CX, Ozpiskin OM, Woloschak G, Grdina DJ, Vaughan AT, Wang JM, Xia S, Monjazeb AM, Murphy WJ, Sun LQ, Chen HW, Lam KS, Weichselbaum RR, Li JJ. PMID: 32929084; PMCID: PMC7490264.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    8. Targeting the polyamine pathway-"a means" to overcome chemoresistance in triple-negative breast cancer. J Biol Chem. 2020 05 08; 295(19):6278-6279. Sweeney C. PMID: 32385094; PMCID: PMC7212642.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Novel approaches for efficient  in vivo fermentation production of noncoding RNAs. Appl Microbiol Biotechnol. 2020 Mar; 104(5):1927-1937. Yu AM, Batra N, Tu MJ, Sweeney C. PMID: 31953559; PMCID: PMC7385725.
      View in: PubMed   Mentions: 15     Fields:    Translation:Cells
    10. Patient-Centered Team-Based Learning in Pre-Clinical Curriculum Supporting the Application of Knowledge to Real-World Clinical Experience. Med Sci Educ. 2020 Mar; 30(1):65-68. Anderson H, Sweeney C, Perry R, Vaquero J, Ison H. PMID: 34457639; PMCID: PMC8368343.
      View in: PubMed   Mentions: 2  
    11. A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells. Cancer Res. 2020 02 01; 80(3):418-429. Umeh-Garcia M, Simion C, Ho PY, Batra N, Berg AL, Carraway KL, Yu A, Sweeney C. PMID: 31694904; PMCID: PMC7002233.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    12. A Protective Role of Aryl Hydrocarbon Receptor Repressor in Inflammation and Tumor Growth. Cancers (Basel). 2019 Apr 27; 11(5). Vogel CFA, Ishihara Y, Campbell CE, Kado SY, Nguyen-Chi A, Sweeney C, Pollet M, Haarmann-Stemmann T, Tuscano JM. PMID: 31035533; PMCID: PMC6563059.
      View in: PubMed   Mentions: 18  
    13. A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials. J Mammary Gland Biol Neoplasia. 2019 06; 24(2):149-162. Pénzváltó Z, Chen JQ, Tepper CG, Davis RR, Silvestrini MT, Umeh-Garcia M, Sweeney C, Borowsky AD. PMID: 30810966; PMCID: PMC6612594.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    14. Cancer prevention through miRNAs: miR-206 prevents the initiation and progression of hepatocellular carcinoma by attenuating c-MET signaling and cell-cycle progression via cyclin D1 and CDK6. Noncoding RNA Investig. 2018 Jun; 2. Umeh-Garcia M, Sweeney C. PMID: 31930188; PMCID: PMC6953971.
      View in: PubMed   Mentions:
    15. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer. Oncogene. 2018 01 11; 37(2):197-207. Rowson-Hodel AR, Wald JH, Hatakeyama J, O'Neal WK, Stonebraker JR, VanderVorst K, Saldana MJ, Borowsky AD, Sweeney C, Carraway KL. PMID: 28892049; PMCID: PMC5930013.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    16. Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination. Oncogene. 2017 09 07; 36(36):5158-5167. Wald JH, Hatakeyama J, Printsev I, Cuevas A, Fry WHD, Saldana MJ, VanderVorst K, Rowson-Hodel A, Angelastro JM, Sweeney C, Carraway KL. PMID: 28481871; PMCID: PMC5589482.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    17. The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3. Sci Signal. 2016 06 28; 9(434):ra65. Hatakeyama J, Wald JH, Rafidi H, Cuevas A, Sweeney C, Carraway KL. PMID: 27353365; PMCID: PMC5554593.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    18. Down-regulatory mechanism of mammea E/BB from Mammea siamensis seed extract on Wilms' Tumor 1 expression in K562 cells. BMC Complement Altern Med. 2016 May 18; 16:130. Rungrojsakul M, Katekunlaphan T, Saiai A, Ampasavate C, Okonogi S, Sweeney CA, Anuchapreeda S. PMID: 27193767; PMCID: PMC4870773.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    19. Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer. Br J Cancer. 2016 05 10; 114(10):1125-34. Amir S, Simion C, Umeh-Garcia M, Krig S, Moss T, Carraway KL, Sweeney C. PMID: 27100732; PMCID: PMC4865973.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    20. Hexamethylene amiloride engages a novel reactive oxygen species- and lysosome-dependent programmed necrotic mechanism to selectively target breast cancer cells. Cancer Lett. 2016 May 28; 375(1):62-72. Rowson-Hodel AR, Berg AL, Wald JH, Hatakeyama J, VanderVorst K, Curiel DA, Leon LJ, Sweeney C, Carraway KL. PMID: 26944316; PMCID: PMC5554595.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    21. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016 06 02; 35(22):2932-47. Yokdang N, Hatakeyama J, Wald JH, Simion C, Tellez JD, Chang DZ, Swamynathan MM, Chen M, Murphy WJ, Carraway Iii KL, Sweeney C. PMID: 26387542; PMCID: PMC4805527.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    22. Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth. Oncogene. 2016 Mar 03; 35(9):1143-52. Morrison MM, Williams MM, Vaught DB, Hicks D, Lim J, McKernan C, Aurisicchio L, Ciliberto G, Simion C, Sweeney C, Cook RS. PMID: 26148232; PMCID: PMC4703573.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    23. The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells. Pestic Biochem Physiol. 2015 May; 120:5-13. Bekki K, Vogel H, Li W, Ito T, Sweeney C, Haarmann-Stemmann T, Matsumura F, Vogel CF. PMID: 25987214; PMCID: PMC4438266.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    24. Mitochondrial MKP1 is a target for therapy-resistant HER2-positive breast cancer cells. Cancer Res. 2014 Dec 15; 74(24):7498-509. Candas D, Lu CL, Fan M, Chuang FY, Sweeney C, Borowsky AD, Li JJ. PMID: 25377473; PMCID: PMC4267894.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    25. The LRIG family: enigmatic regulators of growth factor receptor signaling. Endocr Relat Cancer. 2014; 21(6):R431-43. Simion C, Cedano-Prieto ME, Sweeney C. PMID: 25183430; PMCID: PMC4182143.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    26. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha. BMC Genomics. 2014 Jun 24; 15:520. Frietze S, O'Geen H, Littlepage LE, Simion C, Sweeney CA, Farnham PJ, Krig SR. PMID: 24962896; PMCID: PMC4082627.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    27. Oligomerization of the Nrdp1 E3 ubiquitin ligase is necessary for efficient autoubiquitination but not ErbB3 ubiquitination. J Biol Chem. 2014 Mar 21; 289(12):8570-8. Printsev I, Yen L, Sweeney C, Carraway KL. PMID: 24519943; PMCID: PMC3961680.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    28. Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3). J Biol Chem. 2013 Jul 26; 288(30):21593-605. Rafidi H, Mercado F, Astudillo M, Fry WH, Saldana M, Carraway KL, Sweeney C. PMID: 23723069; PMCID: PMC3724619.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    29. The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression. Cancer Discov. 2012 Jul; 2(7):638-51. Littlepage LE, Adler AS, Kouros-Mehr H, Huang G, Chou J, Krig SR, Griffith OL, Korkola JE, Qu K, Lawson DA, Xue Q, Sternlicht MD, Dijkgraaf GJ, Yaswen P, Rugo HS, Sweeney CA, Collins CC, Gray JW, Chang HY, Werb Z. PMID: 22728437; PMCID: PMC3546490.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    30. Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer. Mol Cancer Res. 2011 Oct; 9(10):1406-17. Krig SR, Frietze S, Simion C, Miller JK, Fry WH, Rafidi H, Kotelawala L, Qi L, Griffith OL, Gray JW, Carraway KL, Sweeney C. PMID: 21821674; PMCID: PMC3196675.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    31. Inhibitory mechanism of pure curcumin on Wilms' tumor 1 (WT1) gene expression through the PKCα signaling pathway in leukemic K562 cells. FEBS Lett. 2011 Jul 21; 585(14):2235-42. Semsri S, Krig SR, Kotelawala L, Sweeney CA, Anuchapreeda S. PMID: 21658388.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    32. Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression. Arch Biochem Biophys. 2011 Aug 01; 512(1):78-86. Vogel CF, Li W, Wu D, Miller JK, Sweeney C, Lazennec G, Fujisawa Y, Matsumura F. PMID: 21640702; PMCID: PMC3135412.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    33. Quantity control of the ErbB3 receptor tyrosine kinase at the endoplasmic reticulum. Mol Cell Biol. 2011 Jul; 31(14):3009-18. Fry WH, Simion C, Sweeney C, Carraway KL. PMID: 21576364; PMCID: PMC3133396.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    34. ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells. Oncogene. 2010 Oct 07; 29(40):5500-10. Krig SR, Miller JK, Frietze S, Beckett LA, Neve RM, Farnham PJ, Yaswen PI, Sweeney CA. PMID: 20661224; PMCID: PMC4256946.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    35. Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors. J Biol Chem. 2010 Sep 10; 285(37):28691-7. Ingalla EQ, Miller JK, Wald JH, Workman HC, Kaur RP, Yen L, Fry WH, Borowsky AD, Young LJ, Sweeney C, Carraway KL. PMID: 20628057; PMCID: PMC2937896.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    36. Microbead arrays for the analysis of ErbB receptor tyrosine kinase activation and dimerization in breast cancer cells. Assay Drug Dev Technol. 2010 Feb; 8(1):27-36. Khan IH, Zhao J, Ghosh P, Ziman M, Sweeney C, Kung HJ, Luciw PA. PMID: 20035613; PMCID: PMC3196214.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    37. Activation of extracellular signal-regulated kinases in social behavior circuits during resident-intruder aggression tests. Neuroscience. 2010 Jan 20; 165(2):325-36. Trainor BC, Crean KK, Fry WH, Sweeney C. PMID: 19874872; PMCID: PMC2814169.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    38. Effects of photoperiod and experience on aggressive behavior in female California mice. Behav Brain Res. 2010 Apr 02; 208(2):528-34. Silva AL, Fry WH, Sweeney C, Trainor BC. PMID: 20060017; PMCID: PMC2831116.
      View in: PubMed   Mentions: 42     Fields:    Translation:Animals
    39. Isolating the effects of social interactions on cancer biology. Cancer Prev Res (Phila). 2009 Oct; 2(10):843-6. Trainor BC, Sweeney C, Cardiff R. PMID: 19789296.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    40. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms. Cancer Res. 2009 Apr 01; 69(7):2845-52. Workman HC, Sweeney C, Carraway KL. PMID: 19293191; PMCID: PMC2745945.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    41. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells. Breast Cancer Res. 2009; 11(5):R70. Workman HC, Miller JK, Ingalla EQ, Kaur RP, Yamamoto DI, Beckett LA, Young LJ, Cardiff RD, Borowsky AD, Carraway KL, Sweeney C, Carraway KL. PMID: 19761616; PMCID: PMC2790847.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    42. Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer. Cancer Res. 2008 Oct 15; 68(20):8286-94. Miller JK, Shattuck DL, Ingalla EQ, Yen L, Borowsky AD, Young LJ, Cardiff RD, Carraway KL, Sweeney C. PMID: 18922900; PMCID: PMC2597648.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    43. Mechanisms of ErbB receptor negative regulation and relevance in cancer. Exp Cell Res. 2009 Feb 15; 315(4):697-706. Fry WH, Kotelawala L, Sweeney C, Carraway KL. PMID: 18706412; PMCID: PMC2667444.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    44. LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII. Oncogene. 2008 Sep 25; 27(43):5741-52. Stutz MA, Shattuck DL, Laederich MB, Carraway KL, Sweeney C. PMID: 18542056; PMCID: PMC3175812.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    45. Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells. Cancer Res. 2008 Mar 01; 68(5):1471-7. Shattuck DL, Miller JK, Carraway KL, Sweeney C. PMID: 18316611.
      View in: PubMed   Mentions: 191     Fields:    Translation:HumansCells
    46. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1. Mol Cell Biol. 2007 Mar; 27(6):2180-8. Cao Z, Wu X, Yen L, Sweeney C, Carraway KL. PMID: 17210635; PMCID: PMC1820496.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    47. Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways. Curr Top Dev Biol. 2007; 78:1-22. Carraway KL, Funes M, Workman HC, Sweeney C. PMID: 17338913.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    48. LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. Mol Cell Biol. 2007 Mar; 27(5):1934-46. Shattuck DL, Miller JK, Laederich M, Funes M, Petersen H, Carraway KL, Sweeney C. PMID: 17178829; PMCID: PMC1820466.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    49. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth. Cancer Res. 2006 Dec 01; 66(23):11279-86. Yen L, Cao Z, Wu X, Ingalla ER, Baron C, Young LJ, Gregg JP, Cardiff RD, Borowsky AD, Sweeney C, Carraway KL. PMID: 17145873.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimalsCells
    50. Co-opted integrin signaling in ErbB2-induced mammary tumor progression. Cancer Cell. 2006 Aug; 10(2):93-5. Carraway KL, Sweeney C. PMID: 16904607.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    51. The mucin Muc4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3. J Biol Chem. 2006 Jul 14; 281(28):19310-9. Funes M, Miller JK, Lai C, Carraway KL, Sweeney C. PMID: 16690615.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    52. ErbB receptor negative regulatory mechanisms: implications in cancer. J Mammary Gland Biol Neoplasia. 2006 Jan; 11(1):89-99. Sweeney C, Miller JK, Shattuck DL, Carraway KL. PMID: 16865534.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    53. Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. Mol Cell Biol. 2004 Sep; 24(17):7748-57. Wu X, Yen L, Irwin L, Sweeney C, Carraway KL. PMID: 15314180; PMCID: PMC506982.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCells
    54. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem. 2004 Nov 05; 279(45):47050-6. Laederich MB, Funes-Duran M, Yen L, Ingalla E, Wu X, Carraway KL, Sweeney C. PMID: 15345710.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansAnimalsCells
    55. Negative regulation of ErbB family receptor tyrosine kinases. Br J Cancer. 2004 Jan 26; 90(2):289-93. Sweeney C, Carraway KL. PMID: 14735165; PMCID: PMC2409562.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    56. The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion. BJU Int. 2004 Jan; 93(1):143-50. Wu X, Obata T, Khan Q, Highshaw RA, De Vere White R, Sweeney C. PMID: 14678387.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    57. The natural history of spondylolysis and spondylolisthesis: 45-year follow-up evaluation. Spine (Phila Pa 1976). 2003 May 15; 28(10):1027-35; discussion 1035. Beutler WJ, Fredrickson BE, Murtland A, Sweeney CA, Grant WD, Baker D. PMID: 12768144.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    58. Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation. J Biol Chem. 2002 Aug 23; 277(34):31214-9. Ravid T, Sweeney C, Gee P, Carraway KL, Goldkorn T. PMID: 12063263.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    59. EGF receptor activation by heterologous mechanisms. Cancer Cell. 2002 Jun; 1(5):405-6. Carraway KL, Sweeney C. PMID: 12124166.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    60. An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels. Proc Natl Acad Sci U S A. 2002 Mar 05; 99(5):2866-71. Diamonti AJ, Guy PM, Ivanof C, Wong K, Sweeney C, Carraway KL. PMID: 11867753; PMCID: PMC122439.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    61. Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors. J Biol Chem. 2001 Jun 22; 276(25):22685-98. Sweeney C, Fambrough D, Huard C, Diamonti AJ, Lander ES, Cantley LC, Carraway KL. PMID: 11297548.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    62. Localization and modulation of ErbB receptor tyrosine kinases. Curr Opin Cell Biol. 2001 Apr; 13(2):125-30. Carraway KL, Sweeney C. PMID: 11248544.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    63. Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage. Oncogene. 2000 Nov 20; 19(49):5568-73. Sweeney C, Carraway KL. PMID: 11114736.
      View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
    64. Ligand discrimination in signaling through an ErbB4 receptor homodimer. J Biol Chem. 2000 Jun 30; 275(26):19803-7. Sweeney C, Lai C, Riese DJ, Diamonti AJ, Cantley LC, Carraway KL. PMID: 10867024.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells